Career support program

Share this page Email this page to a friend Share this page via Twitter Share this page via Facebook Share this page via LinkedIn

The broad aim of the Career Support Program is to build capacity for Cancer Research in NSW by attracting new cancer researchers to NSW and supporting existing researchers to become more skilled and more internationally competitive.

Previous outcomes

Here you can find details of the outcomes of past and currently funded grants in this program stream, including example application forms and guidelines.

2011

Career Development Fellowships

Fulltime Fellowship to provide salary and possible project support to encourage the very best researchers to continue independent cancer research that is nationally and internationally competitive (max $200,000 p.a. x 3 years).
# Recipient Project Title Administering
Institution
Funded
11/CDF/3-05 A/Prof Tracy Bryan Structural and functional analyses of telomerase, a major anti-cancer target Children's Medical Research Institute $300,000
11/CDF/3-25 Dr Tim Molloy Micro-RNA regulation or radiotherapy resistance in cancer Garvan Institute of Medical Research $597, 984
11/CDF/3-26 Prof Elizabeth Musgrove Using functional genomics in breast and pancreatic cancer to define and refine targeted therapies and identify potential cell cycle regulatory oncogenes Garvan Institute of Medical Research $150,000
11/CDF/3-38 Dr Jenny Yingzi Wang Linking Wnt signalling and epigenetic regulation of tumour suppressors - developing novel epigenetic therapies against AML University of New South Wales $600,000
11/CDF/3-39 Prof Wolfgang Weninger Real time visualisation of tumor associated-antigen specific T cell behaviour in vivo University of Sydney $600,000
           $2,247,984

 

Early Career Development Fellowships

Fulltime Fellowship to provide salary and project support to encourage the very best researchers (up to five years postdoc) to choose cancer research as their career and to continue independent research that is nationally and internationally competitive (max $200,000 p.a. x 3 years).
# Recipient Project Title Administering
Institution
Funded
11/ECF/3-01 Dr David Chang Novel Biomarker Guided Therapeutic Strategies for Pancreatic Cancer Garvan Institute of Medical Research $365.491
11/ECF/3-18 Dr Elizabeth Iorns Identifying and characterizing genes that regulate breast tumorigenesis Garvan Institute of Medical Research $600,000
11/ECF/3-43 Dr Claire E Wakefield Prevention and management of psychological distress in families affected by paediatric cancer University of New South Wales $577,535
           $1,543,026

 

2010

Future Research Leader Fellowships

The Cancer Institute NSW Future Research Leaders Fellowships are aimed at encouraging high calibre interstate and international emerging researchers to establish a substantial program of research at a NSW institution.
# Recipient Project Title Administering
Institution
Funded
10/FRL/2-03 Dr Ilse Rooman Defining Molecular Mechanisms of Early Pancreatic Carcinogenesis to Identify Novel Therapeutic and Early Detection Strategies Garvan Institute of Medical Research $999,409.00
10/FRL/3-02 Dr Andrew Burgess Targeting novel G2 and mitotic checkpoint pathways to improve current chemotherapies Garvan Institute of Medical Research $1,208,675.00

 

Early Career Fellowships

3 year fulltime Fellowships to provide salary and project support to encourage the very best researchers (up to five years postdoc) to choose cancer research as their career and to continue independent research that is nationally and internationally competitive (max $200,000 p.a. x 3 years).
# Recipient Project Title Administering
Institution
Funded
10/ECF/2-06 Dr Anne Cust Epidemiological studies of melanoma etiology and prevention University of Sydney $570,954
10/ECF/2-11 Dr Sarah Garnett An early start to cancer prevention - interventions for childhood obesity The Sydney Children's Hospitals Network $560,488
10/ECF/2-15 Dr Patric J Jansson A Novel Targeting Strategy for the Design of New Chemotherapeutics that Overcome Drug Resistance in Lung Cancer: "High-Jacking" the Drug Efflux Pump, P-gp University of Sydney $599,892
10/ECF/2-18 Dr Darius Lane Novel chemotherapeutic approaches for leukaemia: investigating the anti-cancer activity of ascorbate in relation to leukaemic iron metabolism University of Sydney $600,000
10/ECF/2-23 Dr Joshua McCarroll Development of novel multi-targeted RNAi therapies for the treatment of lung cancer University of New South Wales $598,778
10/ECF/2-26 Dr Marina Pajic Individualised genotype guided therapy for the treatment of pancreatic cancer Garvan Institute of Medical Research $599,744
10/ECF/2-29 Dr Manish Patel Oncological and quality of life outcomes following urological cancer treatment. Sydney West Area Health Service $452,004
10/ECF/2-41 Dr Nicole Verrills Targeting a tumour suppressor, PP2A, for new leukaemia therapies. University of Newcastle $600,000
10/ECF/2-44 Dr Jason Wong A bioinformatics and mass spectrometry-based approach for the identification of alternatively spliced and fusion proteins in cancer University of New South Wales $416,891

 

Career Development Fellowships

3 year fulltime Fellowships to provide salary and project support to encourage the very best researchers to continue independent cancer research that is nationally and internationally competitive (max $200,000 p.a. x 3 years).
# Recipient Project Title Administering
Institution
Funded
10/CDF/2-01 Dr Tao Liu Targeting histone demethylase for the prevention and therapy of neuroblastoma University of New South Wales $300,000
10/CDF/2-02 Dr Helen Rizos Manipulating oncogenic-signalling pathways in the genesis and treatment of melanoma University of Sydney $300,000
10/CDF/2-03 Prof Derek Hart The Translation of Dendritic Cell Biology into New Cancer Therapies University of Sydney $596,685
10/CDF/2-08 Dr Georgina Hollway The Roles of Scube2 and Sdf1 in the Development and Progression of Carcinoma. Garvan Institute of Medical Research $593,180
10/CDF/2-11 Dr Deborah Marsh Understanding endocrine tumorigenesis - opportunities for new diagnostics and therapies University of Sydney $300,000
10/CDF/2-23 Dr Georgina Long Determining mechanisms of resistance and heterogeneity of response to novel targeted drugs in metastatic melanoma to improve survival and prevent metastatic disease. University of Sydney $599,895
10/CDF/2-32 Dr Maija Kohonen-Corish Molecular markers and mechanisms of early carcinogenesis and their significance to the treatment of colorectal cancer. Garvan Institute of Medical Research $300,000
10/CDF/2-35 A/Prof Xu Dong Zhang Overcoming Resistance of Metastatic Melanoma to Treatment: 53 Regulation of Mcl-1 via a microRNA-Mediated Pathway in Melanoma Progression and Resistance to Chemotherapy University of Newcastle $300,000
10/CDF/2-36 Dr Kellie Charles Inflammatory biomarkers of chemotherapy response in colorectal cancer University of Sydney $574,509
10/CDF/2-37 Dr Megan Hitchins Genetically-mediated epigenetic inactivation of colorectal cancer genes. University of New South Wales $300,000
10/CDF/2-40 Dr Billie Bonevski Reducing tobacco-related inequalities using community-based behavioural research. University of Newcastle $590,399
10/CDF/2-42 Dr Claire Vajdic Cancer epidemiology in high-risk populations and complex cancers University of New South Wales $246,576

 

Clinical Research Fellowships

3 year grants aimed at strengthening and supporting clinical research in hospitals by providing opportunities for cancer clinicians to develop and sustain long-term careers in clinical research.
# Recipient Project Title Administering
Institution
Funded
10/CRF/1-01 Andrew Biankin
The Australian Pancreatic Cancer Genome Initiative Garvan Institute of Medical Research

$749,022

10/CRF/1-07 Sandra O'Toole Personalised medicine in lung and breast cancer Sydney South West Area Health Service

$745,553

10/CRF/1-09 Richard Anthony Scolyer Identification and validation of biomarkers of prognosis and treatment response in melanoma to effect change in clinical care and patient outcome Sydney South West Area Health Service

$749,202

 

Research Scholar Awards

The Cancer Institute NSW Research Scholar Awards will provide funding opportunities to develop and support outstanding students enrolled in a higher degree who have the potential to develop highly significant careers in cancer research.
# Recipient Project Title Administering
Institution
Funded
10/RSA/1-03 Dimitri Conomos Telomere Structural Abnormalities in Alternative Lengthening of Telomeres Children's Medical Research Institute $57,916
10/RSA/1-05 Bo Gao Genetic Basis of Chemotherapy Response in Epithelial Ovarian Cancer University of Sydney $33,334
10/RSA/1-06 Thomas Guy Strategies to enhance CD4 T cell-mediated anti-tumour immunity Centenary Institute of Cancer Medicine and Cell Biology $60,416
10/RSA/1-07 David Hancock Targeting dendritic cells for cancer immunotherapy Centenary Institute of Cancer Medicine and Cell Biology $31,250
10/RSA/1-10 Judy Jobling Mammographic density as a biomarker for the efficacy of treatment of endocrine therapies used to prevent breast cancer events in randomised controlled clinical trials University of Newcastle $55,016
10/RSA/1-12 Steven Kao The Role of Excision Repair Cross Complementation Group 1 and Thymidylate Synthase Expression in Malignant Pleural Mesothelioma University of Sydney $28,013
10/RSA/1-16 Kevin London The application of F18FDG PET/CT in Paediatric Primary Central Nervous System Tumours The Children`s Hospital at Westmead - Kids Research Institute $23,990
10/RSA/1-21 Danielle Park A small, synthetic imaging agent for dying and dead tumour cells University of New South Wales $22,917
10/RSA/1-23 Emma Eliza Ramsay Investigation of a tumour enzyme as a predictor of patient response to an Australian anti-cancer drug University of New South Wales $58,034
10/RSA/1-27 Camille Short Move More for Life: A tailored physical activity program for Australian breast cancer survivors University of Newcastle $49,849
10/RSA/1-28 Emily Stoddart Characterisation of kinase signaling networks in pancreatic cancer (PC). Garvan Institute of Medical Research $37,500
10/RSA/1-29 Carole Mitch Tactacan Novel tyrosine kinase signaling pathways in pancreatic cancer Garvan Institute of Medical Research $60,416
10/RSA/1-31 Nicole Tom Oxytocin Signalling and Inhibition of Hormone Refractory Prostate Cancer University of Sydney $36,600
10/RSA/1-34 Craig Wallington-Beddoe New Therapeutic Strategies for Acute Lymphoblastic Leukaemia: Combining PP2A activation with mTOR inhibition. University of Sydney $58,334
10/RSA/1-37 Jessie Zhong The Role of NEDD9 in Glioblastoma Infiltration. The Children`s Hospital at Westmead $33,334
10/RSA/1-38 Jerry Zhou Discovery of novel protein biomarkers in colorectal cancer (CRC) with potential application for prognosis or therapeutic targeting University of Sydney $45,833
10/RSA/1-39 Katherine Zyner Characterisation and targeting of four-stranded structures at cancer cell telomeres Children's Medical Research Institute $47,832
$740,584

2009

Career Development Fellowship

3 year full time Fellowships to provide salary and project support to encourage high-quality researchers to continue with/choose cancer as their field of research endeavour.
# Recipient Project Title Administering
Institution
Funded
09/CDF/2-13 Dr Tatyana Chtanova In vivo imaging to investigate the role of immune cells in tumour development. Garvan Institute of Medical Research

$600,000

09/CDF/2-17 Dr Jamie Fletcher Identification of new therapeutic targets in neuroblastoma through ABCC transporter associated pathways. University of New South Wales

$558,845

09/CDF/2-25 Dr Jeremy Henson Telomeric C- Circles and Alternative Lengthening of Telomeres. Children's Medical Research Institutw

$569,748

09/CDF/2-26 Dr Luke Hesson Investigation of the molecular events associated with gene resilencing following withdrawal of epigenetic therapies. University of New South Wales

$599,883

09/CDF/2-32 Dr Kerrie McDonald Combining microRNA with cilengitide: A novel therapeutic approach to impede brain tumour cell migration. University of Sydney

$528,675

09/CDF/2-33 A/Prof Bettina Meiser Psychosocial implications of cancer genetic counselling and testing. University of New South Wales

$599,255

09/CDF/2-37 Dr Sallie Anne Pearson The use, effectiveness and safety of cancer medicines in the real world clinical setting. University of New South Wales

$600,000

09/CDF/2-39 Dr Darren Saunders Integrated Functional Genomics Approach to Identify New Therapeutic Strategies in Cancer Garvan Institute of Medical Research

$560,563

09/CDF/2-40 Dr Christopher Scarlett Novel Targeted Therapies for Pancreatic Cancer. Garvan Institute of Medical Research

$599,681

09/CDF/2-50 A/Prof Pu Xia Targeting inflammation for prevention and treatment of cancer. University of Sydney

$599,397

09/CDF/2-12 Dr Timothy Cheung LIGHT-Mediated Anti-tumour Immunotherapy University of Sydney

withdrawn

$5,816,047

 

Clinical Research Fellowship

3 year grants aimed at strengthening and supporting clinical research in hospitals by providing opportunities for cancer clinicians to develop and sustain long-term careers in clinical research.
# Recipient Project Title Administering
Institution
Funded
09/CRF/2-02 Dr Viola Heinzelmann-Schwarz Anti-glycan antibodies for diagnosis and therapy of ovarian cancer. University of New South Wales $695,500
09/CRF/2-05 Dr Patsy Soon Correlation of serum miRNAs in breast cancer patients with clinical parameters. University of Sydney $430,862
09/CRF/2-07 Dr Janette Vardy Cognitive Function and Fatigue in Cancer Survivors. University of Sydney $750,000
$1,876,362

 

Research Scholar Awards

The Cancer Institute NSW Research Scholar Awards will provide funding opportunities to develop and support outstanding students enrolled in a higher degree who have the potential to develop highly significant careers in cancer research.
# Recipient Project Title Administering
Institution
Funded
09/RSA/1-01 Dr Sam Al-Sohaily Biomarkers of prognosis and response to therapy in rectal cancer Garvan Institute of Medical Research $37,500
09/RSA/1-06 Dr Rachel Dear (nee Shaw) The use of clinical trial registries to develop and evaluate a web site that informs patients about cancer clinical trials and facilitates their decision making University of Sydney $32,500
09/RSA/1-07 Mr Kip Dudgeon Repertoires of human antibody domains Garvan Institute of Medical Research $37,500
09/RSA/1-10 Mr Brian Stewart Gloss Identification of DNA Methylation Markers for Ovarian Cancer Detection. Garvan Institute of Medical Research $37,500
09/RSA/1-11 Miss Candice Grzelak Role of the hepatic Hedgehog pathway in injury and hepatocellular carcinoma Centenary Institute of Cancer Medicine and Cell Biology $62,500
09/RSA/1-12 Dr Carole Abigail Harris Targeted Cancer Therapies: Their use, effectiveness and cost effectiveness in real world clinical practice University of New South Wales $62,500
09/RSA/1-13 Ms Thi Thu Cuc Bach Understanding focal adhesion dynamics in cell migration The Sydney Children's Hospitals Network $50,000
09/RSA/1-18 Dr Belinda Kiely Estimating Survival Duration and Communication of Prognostic Uncertainty in Patients with Incurable Cancer University of Sydney $57,000
09/RSA/1-20 Mr Yong(Brian) Lee Characterisation of signalling pathways associated with disease progression and therapeutic resistance in prostate cancer. Garvan Institute of Medical Research $62,500
09/RSA/1-22 Miss Jia (Jenny) Liu Relationship between folate coenzyme distribution and aberrant DNA methylation in colorectal cancer University of New South Wales $62,500
09/RSA/1-23 Mr Warwick Locke Epigenetic Nanoscaled Biosensors for Advanced Breast Cancer Detection Garvan Institute of Medical Research $62,500
09/RSA/1-26 Ms Michelle Frances Maritz Molecular and functional consequences of directly targeting telomerase components in pre-malignant and cancerous cells University of New South Wales $61,500
09/RSA/1-29 Mr Mitchell O'Connell Towards designer RNA-binding proteins (RBPs) as novel cancer biology probes and therapeutic agents University of Sydney $62,500
09/RSA/1-34 Ms Sarah Randall Biomarkers for personalising colorectal cancer (CRC) chemotherapy Macquarie University $62,500
09/RSA/1-35 Mr Saul Bert Mechanism of Long Range Epigenetic Deregulation in Cancer Garvan Institute of Medical Research $62,500
09/RSA/1-38 Dr Josh Stern Recruitment of human telomerase to telomeres University of Sydney $50,000
09/RSA/1-43 Miss Vivian Turner The role of TRAF2, TRAF3 and cIAPs in multiple myeloma Garvan Institute of Medical Research $62,500
09/RSA/1-44 Mr Tetsuo Yamagishi Development of Novel Chemotherapeutics for the Treatment of Leukaemia that Overcome Drug Resistance University of Sydney $50,000
09/RSA/1-47 Miss Teresa Bonello Developing tropomyosin targeting chemotherapeutics for the treatment of neuroblastoma and melanoma. University of New South Wales $60,500
09/RSA/1-52 Ms Nethia Mohana Kumaran Apoptosis pathways in the drug resistance and pathogenesis of melanoma Centenary Institute of Cancer Medicine and Cell Biology $62,500
$1,099,000

2008

Clinical Research Fellowship

The Cancer Institute NSW Clinical Research Fellowships are aimed at strengthening and supporting clinical research in hospitals by providing opportunities for cancer clinicians to develop and sustain long-term careers in clinical research.
# Recipient Project Title Administering
Institution
Funded
08/CRF/1-04 Rosemary Balleine Molecular grade as prognostic indicator in invasive breast cancer University of Sydney

$577,151

08/CRF/1-05 Michael Buckland Epigenetic changes in gliomas St Vincents Hospital

$754,453

08/CRF/1-06 Stan Sidhu Molecular Markers of Diagnosis, Outcome and Therapeutic Response in Malignant Adrenal Tumours. University of Sydney

$564,126

$1,895,730

 

Early Career Development Fellowship

These Fellowships encourage the very best researchers to choose cancer research as their career and to continue independent research that is nationally and internationally competitive. These Fellowships will support researchers within five years of completing a PhD.
# Recipient Project Title Administering
Institution
Funded
08/ECF/1-02 Dr Viive Howell Ovarian cancer: Experimental models for understanding the molecular events important to this malignancy. University of Sydney $598,790
08/ECF/1-03 Dr Anthony Don The molecular pathway for lymphoma cell death induced with the novel therapeutic

FTY720
University of New South Wales $523,173
08/ECF/1-08 Dr Di Yu Anti-tumour helper T cells: the role of IL-21 and novel approaches for cancer therapy Garvan Institute of Medical Research $587,680
08/ECF/1-10 Dr Marcel Batten The importance of IL-27 signals for the anti-tumour immune response to lymphomas and mammary carcinomas Garvan Institute of Medical Research $574,412
08/ECF/1-12 Dr Alexander Swarbrick The role of the miR-379-656 microRNA cluster in cancer Garvan Institute of Medical Research $593,996
08/ECF/1-18 Dr Luke Wolfenden Supporting parents to increase children's consumption of fruits and vegetables: a randomised controlled trial of a telephone based intervention. University of Newcastle $586,101
08/ECF/1-30 Dr Danuta Kalinowski Development of Novel Anti-Cancer Drugs with Marked and Selective Activity that Overcome Resistance to Established Chemotherapy. University of Sydney $588,598
08/ECF/1-36 Dr Yohan Suryo Rahmanto Novel insights into the role of melanoma tumour antigen p97 (melanotransferrin) in melanoma progression and pathogenesis University of Sydney $593,197
08/ECF/1-37 Dr Phoebe Phillips Role of Heat Shock Proteins in Tumour-Stromal Interactions in Pancreatic Cancer University of New South Wales $598,507
$5,224,454

 

International Clinical and Research Fellowship

These fellowships will place our best future leaders in world renowned cancer centres to complete their training, obtain new ideas and techniques and to develop life-long contacts around the world. The successful applicants bring this training back to New South Wales to enhance our cancer control program.
# Recipient Project Title Administering
Institution
Funded
08/ICR/1-03 Mi Joung Lee Lower limb lymphoedema secondary to cancer treatment. University of Sydney $158,961

 

Research Scholar Award

The Research Scholar Awards aim to develop and support outstanding students enrolled in a higher degree by recognising researchers with the potential to develop highly significant careers in cancer research.
# Recipient Project Title Administering
Institution
Funded
08/RSA/1-02 Mr Scott Penfold Development of Proton Computed Tomography for Application in Proton Radiation Therapy University of Wollongong $25,000
08/RSA/1-07 Ms Elizabeth Shelley Preclinical studies of a novel plant toxin, persin, as an anti-cancer agent. Garvan Institute of Medical Research $50,000
08/RSA/1-09 Mr Simon Junankar Recognition of senescent cancer cells by the immune system Garvan Institute of Medical Research $50,000
08/RSA/1-13 Mrs Cathy Payne Oligodendrogliomas with LOH 1p19q: Identifying Genes associated with Therapeutic Chemosensitivity University of Sydney $50,000
08/RSA/1-15 Dr David Chang Biomarkers of phenotype, prognosis and response to therapy in pancreatic cancer Garvan Institute of Medical Research $50,000
08/RSA/1-16 Ms Joanna Fardell Chemotherapy and cognitive decline: Is exercise a remedy? University of Sydney $50,000
08/RSA/1-18 Mr Christopher Lavis The role of dysregulation of CHOP in adaptation of human melanoma cells to endoplasmic reticulum (ER) stress University of Newcastle $50,000
08/RSA/1-22 Dr Lyndal Jillian Tacon Molecular mechanisms of adrenocortical tumorigenesis and response to therapy. University of Sydney $50,000
08/RSA/1-32 Dr Sarah Walker THE ROLE OF ADIPONECTIN IN HEPATOCELLULAR CARCINOMA University of Sydney $75,000
08/RSA/1-36 Mr George Sharbeen Selective killing of mismatch repair deficient cancer cells Centenary Institute of Cancer Medicine and Cell Biology $25,000
08/RSA/1-37 Miss Zeenia Kaul Defining the role of telomere dysfunction in cellular proliferation barriers Childrens Medical Research Institute $50,000
08/RSA/1-38 Dr Prunella Blinman Determining patients and doctors preferences for chemotherapy and incorporating them into clinical decision making. University of Sydney $35,000
08/RSA/1-44 Ms Jamie Bryant Tackling Tobacco: An exploration of methods to reduce smoking in socially disadvantaged populations University of Newcastle $55,305
08/RSA/1-39 Vivienna Ong The Role of the Grb7 Adaptor Protein in Pancreatic Cancer. Garvan Institute of Medical Research declined
$612,865

 

Future Research Leader Grants

The Cancer Institute NSW Career Development and Support Fellowships - Future Research Leaders Grants are aimed at encouraging high calibre interstate and international emerging researchers to establish a substantial program of research at a NSW institution.

# Recipient Project Title Administering
Institution
Funded
08/FRL/1-02 Dr Paulus Mrass Direct visualization of T cell-tumour stroma cell interactions to dissect the molecular mechanisms of immune system-mediated tumour destruction. University of Sydney

$1,167,710

08/FRL/1-04 Dr Liang Qiao Identification and characterization of liver cancer stem cells and their regulation by Notch signalling. University of Sydney

$1,206,507

$2,374,217

2005-2007

Top of page